Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
17.19
-0.13 (-0.75%)
At close: Aug 13, 2025, 4:00 PM
17.12
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:44 AM EDT
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Eton Pharmaceuticals stock ranges from a low of $26 to a high of $35. The average analyst price target of $29.67 forecasts a 72.60% increase in the stock price over the next year.
Price Target: $29.67 (+72.60%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 29, 2025.
Analyst Ratings
The average analyst rating for Eton Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 → $35 | Strong Buy | Maintains | $33 → $35 | +103.61% | May 29, 2025 |
B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $24 → $26 | Strong Buy | Reiterates | $24 → $26 | +51.25% | May 16, 2025 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $26 → $28 | Strong Buy | Maintains | $26 → $28 | +62.89% | May 14, 2025 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $23 → $26 | Strong Buy | Maintains | $23 → $26 | +51.25% | Mar 19, 2025 |
B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $21 → $24 | Strong Buy | Reiterates | $21 → $24 | +39.62% | Mar 19, 2025 |
Financial Forecast
Revenue This Year
78.46M
from 39.01M
Increased by 101.12%
Revenue Next Year
114.32M
from 78.46M
Increased by 45.71%
EPS This Year
0.28
from -0.15
EPS Next Year
1.31
from 0.28
Increased by 362.65%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 83.5M | 128.0M | 183.0M | ||
Avg | 78.5M | 114.3M | 159.9M | ||
Low | 72.9M | 104.8M | 136.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 114.1% | 63.1% | 60.1% | ||
Avg | 101.1% | 45.7% | 39.8% | ||
Low | 86.9% | 33.6% | 19.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 0.62 | 1.76 | 2.01 | ||
Avg | 0.28 | 1.31 | 1.94 | ||
Low | -0.06 | 0.72 | 1.86 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | 525.1% | 53.6% | ||
Avg | - | 362.6% | 48.8% | ||
Low | - | 153.5% | 42.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.